PARTNER

Caring for lifer and health Making contributions to the health of human beings

Partner
Partner



 

Strategic partner


State Key Laboratory of Biotherapy, Sichuan University

✦ The comprehensive score ranks first in China
✦ 1 academician of Chinese Academy of Sciences
✦ 12 Yangtze River Scholars
✦ 20 recipients of the National Science Fund for Distinguished Young Scholars
✦ 45 experts of the National "Thousand Talents Program"
✦ More than 80 doctoral supervisors
✦ More than 1000 postdoctoral fellows

Beijing Tiantan Hospital, Capital Medical University

Beijing Tiantan Hospital, Capital Medical University was founded on August 23, 1956. It is a grade-3class-A hospital with a neurosurgery unit and a characteristic neuroscience cluster.
 

Clinical partners


Peking Union Medical College Hospital

Peking union medical college hospital, founded in 1921, which is a modern comprehensive tertiary first-class hospital integrating medical treatment, teaching and scientific research under the National Health and Health Commission. it has won reputation in China and overseas by their strong technical force, outstanding specialties, and multi-disciplinary comprehensive advantages.

Beijing Tiantan Hospital, Capital Medical University

Beijing Tiantan Hospital, Capital Medical University was founded on August 23, 1956. It is a grade-3class-A hospital with a neurosurgery unit and a characteristic neuroscience cluster.

West China Hospital of Sichuan University

West China Hospital of Sichuan University is a national center for the diagnosis and treatment of difficult and critical diseases in western China, as well as the largest comprehensive single-point hospital in the world. It has the largest medical laboratory center in China and the earliest one approved by the American Society of Pathologists (CAP).

Fujian Cancer Hospital

As a key institution for cancer prevention, treatment and research across Fujian Province, Fujian Cancer Hospital has built leading strengths in clinical technology, academic disciplines, talent cultivation and patient services for oncology. It boasts distinctive advantages in cancer prevention, control and comprehensive diagnosis & treatment, and serves as the flagship institution guiding cancer management initiatives in Fujian and neighboring regions.

Henan Cancer Hospital

Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University) is the only Grade A tertiary specialized oncology hospital in Henan integrating medical care, disease prevention, scientific research, education and rehabilitation. It was initiated for construction in 1977 and officially put into operation in 1984, and was accredited as the Affiliated Cancer Hospital of Zhengzhou University in 2010. After 45 years of development, it has grown into a large modern hospital with leading cancer prevention and treatment capacity in Henan and nationwide renowned expertise in the field.

Sun Yat-sen University Cancer Center

Sun Yat-sen University Cancer Center (SYSUCC, also known as Affiliated Cancer Hospital & Cancer Institute of Sun Yat-sen University) was founded in March 1964 and ranks among China’s first four cancer hospitals established after the founding of the People’s Republic of China.
As one of the country’s largest and most academically robust comprehensive oncology hubs integrating clinical care, education, scientific research and disease prevention, the center undertakes core national tasks for cancer prevention and treatment. It acts as a flagship institute for cancer control across China, particularly in South China, Hong Kong, Macao and Taiwan, with its academic standing and comprehensive capabilities leading the domestic oncology sector.
 

Other cooperative units


China National Pharmaceutical Group Co., Ltd.

China National Pharmaceutical Group (Sinopharm for short), directly supervised by the State-owned Assets Supervision and Administration Commission of the State Council (SASAC), is China’s largest pharmaceutical and healthcare conglomerate featuring the most complete industrial chain and top comprehensive strength in the industry.

Hangzhou Tigermed Consulting Co., Ltd.

Headquartered in Hangzhou, the company boasts an international professional workforce of over 2,500 employees and has delivered more than 600 clinical trial services for over 600 clients worldwide. Having participated in clinical trials for over 80 domestic innovative medicines, Tigermed is reputed as an "innovative CRO".

Pharmaron (Beijing) New Drug Development Co., Ltd.

Founded in 2003 as a wholly US-owned enterprise, the firm provides comprehensive preclinical R&D services for global pharmaceutical enterprises and biopharmaceutical research institutes. It is the largest drug R&D service provider among China’s northern CRO players and the country’s first CRO qualified to deliver preclinical toxicology services complying with GLP standards of Europe and the United States.